Amouyal Philippe Insider Trades

Insider Trading History

Track insider trading activity for Amouyal Philippe. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cava Group
Cava Group CAVA
Director
Holding Value $1.4M 19,955 shares
Last Trade
Jun 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$152k 1,881 shares
$80.88
$69.97
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $0 0 shares
Last Trade
Jun 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$165k 89,312 shares
$1.85
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $794k 374,486 shares
Last Trade
Jun 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$165k 89,312 shares
$1.85
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $92.2k 43,478 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 79,192 shares
$1.63
$2.12
Cava Group
Cava Group CAVA
Director
Holding Value $1.26M 18,074 shares
Last Trade
Jun 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$132k 1,767 shares
$74.62
$69.97
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $220k 103,806 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$122k 193,118 shares
$0.63
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $605k 285,174 shares
Last Trade
May 13, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23.2k 36,810 shares
$0.63
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $0 0 shares
Last Trade
May 13, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23.2k 36,810 shares
$0.63
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $95.2k 44,906 shares
Last Trade
May 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$80.4k 44,906 shares
$1.79
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $527k 248,364 shares
Last Trade
Apr 28, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.7k 8,032 shares
$1.58
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $0 0 shares
Last Trade
Apr 28, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.7k 8,032 shares
$1.58
$2.12
Cava Group
Cava Group CAVA
Director
Holding Value $1.05M 15,000 shares
Last Trade
Nov 17, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$332k 10,000 shares
$33.18
$69.97
Cava Group
Cava Group CAVA
Director
Holding Value $350k 5,000 shares
Last Trade
Jun 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$192k 5,000 shares
$38.43
$69.97
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $85.5k 40,332 shares
Last Trade
May 21, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28k 9,302 shares
$3.01
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $0 0 shares
Last Trade
May 21, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28k 9,302 shares
$3.01
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $26.8k 12,658 shares
Last Trade
Apr 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.9k 12,658 shares
$2.36
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $30.5k 14,402 shares
Last Trade
May 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.5k 14,402 shares
$1.77
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $0 0 shares
Last Trade
Apr 30, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.28k 4,024 shares
$1.81
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $13.7k 6,475 shares
Last Trade
Apr 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51k 10,499 shares
$4.86
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $57.3k 27,006 shares
Last Trade
Apr 24, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$52.9k 10,638 shares
$4.97
$2.12

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up